Aldeyra Therapeutics, Inc.

Go to Aldeyra Therapeutics, Inc. Website

$5.24

0.08 (1.55%)
Live
Previous Close

$5.16

Day Range

$5.05 - $5.29

Previous Day Range

$4.99 - $5.23

Market Cap

$304.3 million USD

Day Vol.

407185

Previous Day Vol.

1.3 million

Currency

USD

Primary Exchange

Nasdaq

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a tr...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Bragar Eagel & Squire, P.C. is investigating potential claims against Organon, Aldeyra, Landstar, and ICU Medical due to issues related to financial results, regulatory matters, and accounting fraud.

Related tickers: OGN, ALDX, LSTR, ICUI.

Read Full Article

Aldeyra Therapeutics, a biotechnology company, is being investigated for potential securities law violations related to the failure of its Phase III dry eye disease drug trial. The company's stock price declined significantly after the FDA issued a Complete Response Letter citing concerns with the trial data.

Related tickers: ALDX.

Read Full Article
Trending Tickers

Please sign in to view